Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Trial Summary
What is the purpose of this trial?
The purpose of this 1 year study is to see if the ICCAN program is working, and to compare the ICCAN program to the standard hospital services provided in New York City hospitals, like meeting with a Social Worker or a Patient Navigator (a person who provides personal hospital guidance).
Research Team
Francesca Gany, MD, MS
Principal Investigator
Memorial Sloan Kettering Cancer Center
Eligibility Criteria
Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the ICCAN program or standard hospital services for cancer treatment
Follow-up
Participants are monitored for treatment completion and quality of life outcomes
Treatment Details
Interventions
- The Integrated Cancer Care Access Network (ICCAN)
- Usual and Customary Group (U&C)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Ralph Lauren Center for Cancer Care and Prevention
Collaborator
The City College of New York
Collaborator
Lincoln Medical and Mental Health Center
Collaborator
Lutheran Medical Center
Collaborator
National Cancer Institute (NCI)
Collaborator